Ligand validation:4XPI

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4XPI_GOL_B_605	57%	71%	0.122	0.897	0.23	0.86	-	-	2	0	100%	1
4XPI_GOL_D_603	36%	83%	0.163	0.856	0.38	0.4	-	-	0	0	100%	1
4XPI_GOL_B_603	28%	69%	0.147	0.796	0.46	0.74	-	-	3	0	100%	1
4XPI_GOL_B_606	26%	64%	0.218	0.86	0.4	0.98	-	-	1	0	100%	1
4XPI_GOL_B_607	19%	67%	0.32	0.915	0.31	0.93	-	-	4	0	100%	1
4XPI_GOL_D_601	18%	90%	0.174	0.755	0.4	0.21	-	-	0	0	100%	1
4XPI_GOL_C_504	15%	75%	0.205	0.764	0.43	0.56	-	-	3	0	100%	1
4XPI_GOL_A_503	14%	81%	0.177	0.721	0.18	0.63	-	-	0	0	100%	1
4XPI_GOL_C_507	12%	43%	0.202	0.73	0.86	1.33	-	-	2	0	100%	1
4XPI_GOL_C_506	10%	73%	0.329	0.842	0.49	0.54	-	-	0	0	100%	1
4XPI_GOL_C_503	10%	50%	0.205	0.709	0.47	1.42	-	1	0	0	100%	1
4XPI_GOL_B_608	10%	19%	0.328	0.83	1.11	2.28	1	1	7	0	100%	1
4XPI_GOL_B_602	7%	62%	0.26	0.713	0.64	0.82	-	-	1	0	100%	1
4XPI_GOL_C_505	3%	32%	0.354	0.703	0.99	1.67	1	1	4	0	100%	1
4XPI_GOL_C_508	1%	65%	0.439	0.622	0.63	0.71	-	-	10	0	100%	1
6UG0_GOL_D_601	42%	54%	0.156	0.876	0.79	1	-	-	0	0	100%	1
8P8G_GOL_B_611	1%	94%	0.306	0.428	0.09	0.35	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.